Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.

@article{Adams2007HumanPV,
  title={Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.},
  author={Madeleine Adams and Bharat Jasani and Alison Nina Fiander},
  journal={Vaccine},
  year={2007},
  volume={25 16},
  pages={3007-13}
}
Prophylactic vaccination against high risk human papilloma virus (HPV) 16 and 18 represents an exciting means of protection against HPV related malignancy. However, this strategy alone, even if there is a level of cross protection against other oncogenic viruses, cannot completely prevent cervical cancer. In some developed countries cervical screening programmes have reduced the incidence of invasive cervical cancer by up to 80% although this decline has now reached a plateau with current… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 58 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 30 references

3007–3013 Table 2 Lifetime impact of vaccination combine with cervical screening on outcomes for different scenario cohorts in the UK

  • M. Adams
  • Vaccine
  • 2007

HPV and anogenital cancer. Vaccine 2006;24S3:S3/42–51

  • TC Wright, P Van Damme, HJ Schmitt, A. Meheus
  • 2006

HPV vaccine introduction in industrialised countries

  • TC Wright, P VanDamme, HJ Schmitt, A Meheus
  • Vaccine
  • 2006

Similar Papers

Loading similar papers…